Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 288.73 USD -0.95% Market Closed
Market Cap: 20.3B USD

Intrinsic Value

The intrinsic value of one PODD stock under the Base Case scenario is 197.27 USD. Compared to the current market price of 288.73 USD, Insulet Corp is Overvalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PODD Intrinsic Value
197.27 USD
Overvaluation 32%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Insulet Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about PODD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PODD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Insulet Corp.

Explain Valuation
Compare PODD to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Growing competitive pressure from larger diabetes-technology players, especially Medtronic and Tandem, could slow OmniPod adoption if rival products offer compelling new features or pricing structures.

Insulet’s heavy reliance on the OmniPod franchise increases vulnerability to any manufacturing issues or quality-control setbacks, potentially leading to supply disruptions or product recalls that weigh on brand reputation.

Pressure from insurers and healthcare systems on device reimbursement could squeeze profit margins if Insulet faces downward pricing for its pods, reducing the company’s ability to invest in R&D or marketing.

Bull Theses

The rapid uptake of Insulet’s OmniPod system, thanks to tubeless convenience and user-friendly design, positions Insulet as a category leader in an expanding insulin-pump market.

Insulet’s upcoming integrations with continuous glucose monitoring solutions, such as Dexcom and Abbott, could create a superior closed-loop system that appeals to a broader patient base, boosting adoption rates and recurring pod sales.

Recurring revenue from OmniPod’s disposable pods ensures a stable, predictable stream of income, enabling Insulet to reinvest in next-generation pump technologies and global market expansion.

Show More Less
How do you feel about PODD?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Insulet Corp

Current Assets 1.9B
Cash & Short-Term Investments 627.2m
Receivables 462.2m
Other Current Assets 770m
Non-Current Assets 1.2B
PP&E 724.1m
Intangibles 156.6m
Other Non-Current Assets 289.2m
Current Liabilities 647.7m
Accounts Payable 48.2m
Accrued Liabilities 519.6m
Other Current Liabilities 79.9m
Non-Current Liabilities 997.5m
Long-Term Debt 934.9m
Other Non-Current Liabilities 62.6m
Efficiency

Free Cash Flow Analysis
Insulet Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Insulet Corp

Revenue
2.5B USD
Cost of Revenue
-719.7m USD
Gross Profit
1.8B USD
Operating Expenses
-1.4B USD
Operating Income
436.9m USD
Other Expenses
-190.7m USD
Net Income
246.2m USD
Fundamental Scores

PODD Profitability Score
Profitability Due Diligence

Insulet Corp's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
61/100
Profitability
Score

Insulet Corp's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

PODD Solvency Score
Solvency Due Diligence

Insulet Corp's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
63/100
Solvency
Score

Insulet Corp's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PODD Price Targets Summary
Insulet Corp

Wall Street analysts forecast PODD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PODD is 385.61 USD with a low forecast of 319.16 USD and a high forecast of 453.6 USD.

Lowest
Price Target
319.16 USD
11% Upside
Average
Price Target
385.61 USD
34% Upside
Highest
Price Target
453.6 USD
57% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Insulet Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for PODD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PODD Insider Trading
Buy and sell transactions by insiders

PODD News

Other Videos
What is the Intrinsic Value of one PODD stock?

The intrinsic value of one PODD stock under the Base Case scenario is 197.27 USD.

Is PODD stock undervalued or overvalued?

Compared to the current market price of 288.73 USD, Insulet Corp is Overvalued by 32%.

Back to Top